Pyoderma gangrenosum: update and guidance

Introduction: The pyoderma gangrenosum (PG) is a neutrophilic disease, rare but with a poor outcome. The Capitulum of Wound treatment of the Brazilian Society of Plastic Surgery (SBCP) promoted a discussion with the Brazilian societies of Dermatology and Rheumatology to extract the best procedures i...

Full description

Saved in:
Bibliographic Details
Published inRevista Brasileira de cirurgia plástica Vol. 37; no. 4; pp. 423 - 430
Main Authors Vieira, Luiz Felipe Duarte Fernandes, Almeida, Carlos Lacerda Andrade, Souza, Alexandre Wagner de, Rêgo, Jozelia, Vale, Everton Siviero do, Pegas, Jose Roberto Pereira
Format Journal Article
LanguageEnglish
Published Thieme Revinter Publicações Ltda 01.12.2022
Subjects
Online AccessGet full text
ISSN2177-1235
1983-5175
2177-1235
DOI10.5935/2177-1235.2022RBCP.671-en

Cover

More Information
Summary:Introduction: The pyoderma gangrenosum (PG) is a neutrophilic disease, rare but with a poor outcome. The Capitulum of Wound treatment of the Brazilian Society of Plastic Surgery (SBCP) promoted a discussion with the Brazilian societies of Dermatology and Rheumatology to extract the best procedures in diagnostic and treatment. Methods: Broad review of published articles related to the subject and compilation of guidelines of diagnostic and treatment by two advisors of each involved society, plastic surgery, dermatology and rheumatology. Results: The PG is not an exclusion disease anymore, with well defined criteria for its diagnostic and literature based treatment, refined by the authors, including the use of biological therapies. Conclusion: The PG remains challenging, but systematizing the investigation and the use of new drugs has opened a new horizon of treatments, interfering in the pathophysiology in a positive manner with fewer side effects than immunosuppressive therapy alone.
ISSN:2177-1235
1983-5175
2177-1235
DOI:10.5935/2177-1235.2022RBCP.671-en